Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

OBJECTIVE: To conduct a cost-effectiveness analysis from payers’ perspectives of six treatments for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) and to examine positioning of these modalities in the marketplace for the best use of health care funds and quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulchaker, James C, Martinson, Melissa S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749396/
https://www.ncbi.nlm.nih.gov/pubmed/29343977
http://dx.doi.org/10.2147/CEOR.S148195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749396/
https://www.ncbi.nlm.nih.gov/pubmed/29343977
http://dx.doi.org/10.2147/CEOR.S148195

Ejemplares similares